Ketamine, first synthesized in 1962 and FDA-approved in 1970, is a versatile medication with a broad range of applications. Initially developed as a safer alternative to phencyclidine (PCP), ketamine is widely used in anesthesia and emergency medicine due to its unique ability to maintain respiratory function and cardiovascular stability.
In recent years, ketamine has gained significant attention for its off-label use in treating mental health disorders such as treatment-resistant depression (TRD), bipolar disorder, and post-traumatic stress disorder (PTSD). Ketamine infusion therapy has shown rapid antidepressant effects, often providing symptom relief within hours, unlike traditional antidepressants that take weeks to work. However, ketamine is also a controlled substance due to its dissociative properties and potential for abuse. This article explores ketamine’s medical and therapeutic applications, its side effects, legal classification, and risks associated with recreational use.
Ketamine remains a crucial anesthetic in medical and surgical procedures, particularly in high-risk environments such as emergency rooms, war zones, and pediatric surgeries. Unlike other general anesthetics, ketamine preserves protective airway reflexes and does not cause respiratory depression, making it ideal for trauma patients where intubation may be challenging.
Ketamine injection is often used in surgeries and diagnostic procedures that do not require muscle relaxation.
Ketamine’s drug dose for anesthesia varies based on administration routes:
Ketamine’s antidepressant effects, discovered in the early 2000s, have transformed psychiatric treatment for patients with severe depression, suicidal ideation, and PTSD.
Chronic pain conditions such as complex regional pain syndrome (CRPS), fibromyalgia, and chemotherapy-induced neuropathy often show resistance to conventional painkillers. Ketamine, through its NMDA receptor antagonist properties, interrupts pain signaling and central sensitization.
Ketamine’s dissociative and hallucinogenic effects have led to its widespread recreational use, particularly in party and club settings.
Asana Recovery works with most PPO plans, covering up to 100%. See if your insurance can help fund your journey. Click below to get a free quote.
In medical settings, ketamine is administered through intravenous (IV) infusions, intramuscular (IM) injections, and subcutaneous injections.
Although ketamine is most commonly used as an injection or infusion, alternative formulations are emerging:
Patients receiving ketamine may experience:
Unlike traditional antidepressants, ketamine works through glutamate modulation, enhancing synaptic plasticity and promoting neural growth.
Ketamine is classified as a Schedule III drug, meaning:
Ketamine remains a double-edged sword in medicine. While its anesthetic and antidepressant effects offer hope to those struggling with severe pain and mood disorders, its potential for abuse underscores the need for careful regulation. Patients considering ketamine therapy should consult experienced professionals and weigh the benefits against the risks.
As ongoing research uncovers new ketamine medical uses, its role in mental health and pain management may expand. However, misuse can have serious consequences, making education and regulation essential in ensuring its responsible use.
If you or a loved one is struggling with substance use or mental health challenges, understanding treatment options like ketamine therapy is essential. At Asana Recovery, we provide compassionate, evidence-based care designed to support long-term recovery. Our expert team offers personalized treatment plans tailored to your unique needs, ensuring you receive the highest quality care. Contact us today to learn more about our programs and take the first step toward a healthier future.
We get it. Addiction recovery is tough. That’s why our programs are founded and staffed by people in recovery – people who truly understand.
Ketamine is primarily used for general anesthesia, pain management, and mental health treatments. It is prescribed for surgical procedures, chronic pain conditions, and off-label for depression, PTSD, and anxiety. Ketamine infusion therapy has gained recognition for its rapid antidepressant effects, making it a promising option for treatment-resistant depression.
Ketamine belongs to the general anesthetics drug class and is classified as a Schedule III controlled substance by the DEA. It acts as an NMDA receptor antagonist, affecting neurotransmitter activity in the brain, which contributes to its anesthetic and antidepressant properties.
Ketamine doses vary based on the medical condition it is being used for. For anesthesia, intravenous (IV) doses typically range from 1–4.5 mg/kg, while intramuscular (IM) doses range from 6.5–13 mg/kg. Lower doses of ketamine, around 0.5 mg/kg, are used in ketamine infusion therapy for depression and pain management.
Yes, ketamine is widely used for general anesthesia due to its ability to induce a dissociative state while maintaining respiratory function. It is especially useful in emergency medicine and surgical settings where intubation is not feasible.
Ketamine can be administered in various forms, including IV infusion, intramuscular injection, oral tablets, nasal spray, and topical cream. Ketamine infusions are the most common method for treating depression and chronic pain.
Common side effects of ketamine include dizziness, nausea, blurred vision, and increased blood pressure. Some individuals may experience ketamine infusion side effects such as dissociation, hallucinations, or confusion. Long-term ketamine use may result in bladder issues, memory impairment, or psychological dependence.
Ketamine hydrochloride is used as an injectable anesthetic and is also prescribed for pain management and psychiatric treatments. It is available in ketamine injection form for medical procedures and as ketamine tablets or ketamine capsules for research and therapeutic use.
Esketamine (Spravato) is a nasal spray derived from ketamine that has been FDA-approved for treatment-resistant depression. While ketamine is often administered via IV or IM, esketamine offers an alternative for those seeking non-invasive treatment options for depression.
Ketamine is contraindicated in individuals with uncontrolled high blood pressure, schizophrenia, severe cardiovascular disease, or a history of substance abuse disorder. Patients with ketamine contraindications should consult a healthcare provider before considering treatment.
Yes, ketamine pills and ketamine tablets are available, but they are not FDA-approved for widespread use. Compounded ketamine capsules and troches are sometimes prescribed off-label for depression or chronic pain.
Ketamine therapy involves administering low-dose ketamine infusions or nasal sprays to treat depression, PTSD, and chronic pain conditions. Ketamine’s mechanism of action enhances neuroplasticity, allowing the brain to form new neural connections and improve mood and cognitive function.
Prescription ketamine is regulated and typically requires in-person consultations. However, some telemedicine providers offer ketamine prescription services for oral ketamine therapy under medical supervision.
The effects of ketamine depend on the dose and route of administration. When used for anesthesia, ketamine’s effects last about 30–45 minutes. For mental health treatments, the antidepressant effects of ketamine infusion therapy can last from days to weeks, requiring maintenance sessions.
No, ketamine is not a narcotic or opioid. It is a dissociative anesthetic classified under the general anesthetics drug class. Unlike opioids, ketamine does not cause respiratory depression, making it a safer alternative for pain management in some cases.
While ketamine is not FDA-approved for anxiety, some studies suggest that it may help with severe anxiety disorders, including generalized anxiety disorder (GAD) and social anxiety disorder. Ketamine therapy for anxiety is considered an off-label use.
Long-term use of ketamine can lead to bladder damage (ketamine bladder syndrome), cognitive impairment, liver toxicity, and psychological dependence. Individuals using ketamine for depression or pain management should be closely monitored by a healthcare provider.
The cost of ketamine therapy varies depending on the treatment provider and location. IV ketamine infusions typically cost between $400–$800 per session, while esketamine (Spravato) nasal spray may range from $590–$885 per dose. Most insurance providers do not cover ketamine therapy for depression.
Ketamine infusion therapy is not FDA-approved for depression, but esketamine (Spravato) is FDA-approved for treatment-resistant depression. Ketamine infusions are considered an off-label treatment for mood disorders.
Yes, ketamine is a controlled substance and requires a prescription from a licensed healthcare provider for medical use. Ketamine prescription pills, injections, and nasal sprays are only available through regulated medical channels.
Yes, ketamine is legally prescribed for anesthesia, pain management, and off-label depression treatment. However, recreational use is illegal, and ketamine is classified as a Schedule III controlled substance under U.S. federal law.
Ketamine is used for chronic pain conditions, including neuropathic pain, fibromyalgia, and complex regional pain syndrome (CRPS). Low-dose ketamine infusions are effective in reducing pain and minimizing opioid dependency.
Ketamine infusion is delivered intravenously in a clinical setting, while ketamine nasal spray (such as Spravato) is self-administered under medical supervision. Both are used to treat depression, but their effects and bioavailability differ.
Ketamine should only be taken under medical supervision. The correct ketamine dosage depends on the intended use, whether for anesthesia, depression, or pain relief. Self-medicating or using ketamine recreationally can lead to severe health risks.
Yes, ketamine is sometimes administered as a post-surgical analgesic to reduce opioid use. Ketamine injection dose for post-operative pain relief is carefully monitored to minimize side effects.
Short-term ketamine use may cause mild memory impairment, but these effects are usually temporary. However, chronic recreational ketamine use has been associated with long-term cognitive deficits and learning difficulties.
Recreational ketamine use can lead to serious health risks, including hallucinations, dissociation, bladder damage, and addiction. High doses can cause respiratory depression, unconsciousness, or overdose.
While ketamine therapy for depression and pain management has shown positive results, the long-term safety of repeated ketamine use is still under investigation. Patients should follow medical guidelines and avoid excessive or unsupervised use.
Ketamine is a powerful and multifaceted drug with significant medical benefits and potential risks. Whether used for anesthesia, depression, or chronic pain, understanding ketamine’s uses, side effects, and proper dosing is essential for safe and effective treatment.
Take your first step towards lasting recovery. At Asana, we offer effective, insurance-covered treatment for addiction and mental health, guided by experts who understand because they’ve been there. Start your healing today.
This book has helped so many men and women; and we want to give it you for FREE. Get signed up today and discover how to unlock the grip of addiction and get back to living your best life.
In this book, you’ll discover…
— The Most Common Misconceptions About Addiction and Rehab
— Why Rock Bottom is a Myth and What You Can Do About It
–The Steps to Healing From Trauma, Both Mentally and Emotionally
–And much more!
Asana Recovery is licensed and certified by the State Department of Health Care Services.
© Copyright 2024 Asana Recovery™ | All Rights Reserved | Privacy Policy
You could save up to 100% of your treatment using your Insurance.
Asana Recovery
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to